Chlorambucil
کلرامبوسیل
🎗️ Antineoplastic And Immunomodulating AgentsOral alkylating agent
Market / country: 🇺🇸 USA
Leukeran (US)
🧮 Dose calculator
Chronic lymphocytic leukaemia (CLL) · Regimen source: FDA Leukeran · Dosage and Administration
- • Usually 4–10 mg/day; whole dose at once. Adjust to response and counts; reduce if counts fall. FDA Leukeran · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Prior disease resistance to chlorambucil; hypersensitivity (possible cross skin hypersensitivity with other alkylators). FDA Leukeran · Contraindications
Warnings
- • Carcinogenic — only for CLL or lymphoma. Seizures, infertility, leukaemia and secondary malignancy; bone-marrow suppression. FDA Leukeran · Warnings
Formulations
- 2 mg tablet — tablet 🇺🇸 USA FDA Leukeran · How Supplied
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Leukeran · Pregnancy
“Chlorambucil can cause fetal harm when administered to a pregnant woman.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Leukeran · Lactation
“Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from chlorambucil, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Leukeran · Pediatric Use
“The safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Leukeran · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA010669
- DailyMed (FDA label)FDA Leukeran
- MedlinePlus (NIH)Chlorambucil
- WHO ATC/DDDL01AA02
- Darooyab (Iran)Chlorambucil
🇮🇷 Registered in Iran Darooyab · G-967/Chlorambucil
Dosage forms with Iranian generic codes, per Darooyab.
- 00262 · CHLORAMBUCIL 2MG TAB · قرص کلرامبوسیل ۲ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Leukeran · How SuppliedFDA Leukeran · Dosage and AdministrationFDA Leukeran · ContraindicationsFDA Leukeran · WarningsFDA Leukeran · PregnancyFDA Leukeran · LactationFDA Leukeran · Pediatric UseFDA Leukeran · Geriatric UseFDA Leukeran · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-967/Chlorambucil
- Clinical review⚠ Unverified